Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.73
-0.58 (-2.86%)
At close: Oct 23, 2026, 4:00 PM EDT
19.62
-0.11 (-0.54%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Acadia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $35 | Buy | Reiterates | $35 | +77.39% | Oct 19, 2026 |
| UBS | UBS | Hold Downgrades $49 → $23 | Hold | Downgrades | $49 → $23 | +16.57% | Oct 13, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $34 | Buy | Maintains | $34 | +72.33% | Oct 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $31 | Buy | Reiterates | $31 | +57.12% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $37 → $36 | Buy | Maintains | $37 → $36 | +82.46% | Oct 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $37 → $33 | Buy | Maintains | $37 → $33 | +67.26% | Sep 25, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Reiterates $38 → $31 | Buy | Reiterates | $38 → $31 | +57.12% | Sep 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $36 | Buy | Reiterates | $36 | +82.46% | Sep 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.